Key facts
- Notable investors include Czech Founders VC.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Spicy Cells
- ·The full record, as it builds
Funding rounds
No funding rounds for Spicy Cells are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Spicy Cells
Developer of a biotechnology-based saffron cultivation process designed to provide a sustainable alternative to traditional field-grown production. The company uses cell-based cultivation methods to grow saffron directly from plant cells, applies controlled bioprocessing to manage quality and yield, and focuses on scalable production that reduces dependence on climate-sensitive agriculture, enabling food, supplement, and ingredient manufacturers to access consistent, higher-quality saffron at more stable and potentially lower costs.
- Sector
- Healthcare
- HQ
- Prague, Czech Republic
- Founded
- 2025
- Employees
- 2
- Website
- spicycells.com/
- Ownership
- Privately Held (backing)
Spicy Cells doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Spicy Cells shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Spicy Cells in its N-PORT filings yet. We sweep new filings monthly.